Lumibird SA

Paris Stock Exchange LBIRD.PA

Lumibird SA Shareholders' Equity for the year ending December 31, 2023: USD 213.36 M

Lumibird SA Shareholders' Equity is USD 213.36 M for the year ending December 31, 2023, a 3.09% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Lumibird SA Shareholders' Equity for the year ending December 31, 2022 was USD 206.97 M, a 0.27% change year over year.
Lumibird SA Shareholders' Equity for the year ending December 31, 2021 was USD 206.41 M, a 2.98% change year over year.
Lumibird SA Shareholders' Equity for the year ending December 31, 2020 was USD 200.44 M, a 42.95% change year over year.
Lumibird SA Shareholders' Equity for the year ending December 31, 2019 was USD 140.22 M, a 34.96% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

Paris Stock Exchange: LBIRD.PA

Lumibird SA

CEO	Dr. Marc Le Flohic
IPO Date	April 12, 2000
Location	France
Headquarters	2 rue Paul Sabatier
Employees	1,053
Sector	Technology
Industries 3D Printing Biotechnology Defense & Military Drones Eyewear Hardware & Electronics Medical Instruments Robotics

Description

Lumibird SA designs, manufactures, and sells various lasers for the scientific, industrial, and medical applications worldwide. It operates in two divisions, Photonics and Medical. The Photonics division offers solid-state lasers, high power laser diodes, fiber lasers, fiber amplifiers and components, photonics solutions for time-of-flight lidar and range-finding, and doppler lidar systems for wind measurement. Its products are used in various applications, such as industrial and scientific, defense and space, and lidar sensors. The Medical division provides medical and ophthalmological solutions from diagnosis to laser treatment. The company was founded in 1970 and is headquartered in Lannion, France.

Key trends

Past 5 years